{"result": "(\"entity\"<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>ORGANIZATION<|>La Fe Hospital Universitari i Politècnic is a university hospital likely located in a Spanish-speaking country, involved in medical education and healthcare services.)\n##\n(\"entity\"<|>C. FUENTES SOCORRO<|>PERSON<|>C. Fuentes Socorro is one of the authors discussing complications related to long-term central venous catheters in pediatrics.)\n##\n(\"entity\"<|>I. VITORIA MIÑANA<|>PERSON<|>I. Vitoria Miñana is one of the authors discussing complications related to long-term central venous catheters in pediatrics.)\n##\n(\"entity\"<|>E. LÓPEZ BRIZ<|>PERSON<|>E. López Briz is one of the authors discussing complications related to long-term central venous catheters in pediatrics.)\n##\n(\"entity\"<|>C. RIBES KONINCKX<|>PERSON<|>C. Ribes Koninckx is one of the authors discussing complications related to long-term central venous catheters in pediatrics.)\n##\n(\"entity\"<|>R. SANCHÍS RAMADA<|>PERSON<|>R. Sanchís Ramada is one of the authors discussing complications related to long-term central venous catheters in pediatrics.)\n##\n(\"entity\"<|>C. GUTIÉRREZ SAN ROMAN<|>PERSON<|>C. Gutiérrez San Roman is one of the authors discussing complications related to long-term central venous catheters in pediatrics.)\n##\n(\"entity\"<|>J. DALMAU SERRA<|>PERSON<|>J. Dalmau Serra is one of the authors discussing complications related to long-term central venous catheters in pediatrics.)\n##\n(\"entity\"<|>CENTRAL VENOUS CATHETER (CVC)<|>EVENT<|>Central Venous Catheter (CVC) is a medical device used for long-term intravenous access, which can lead to complications such as obstruction in pediatric patients.)\n##\n(\"relationship\"<|>C. FUENTES SOCORRO<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>C. Fuentes Socorro is an author affiliated with La Fe Hospital Universitari i Politècnic, contributing to research on pediatric care.<|>7)\n##\n(\"relationship\"<|>I. VITORIA MIÑANA<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>I. Vitoria Miñana is an author affiliated with La Fe Hospital Universitari i Politècnic, contributing to research on pediatric care.<|>7)\n##\n(\"relationship\"<|>E. LÓPEZ BRIZ<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>E. López Briz is an author affiliated with La Fe Hospital Universitari i Politècnic, contributing to research on pediatric care.<|>7)\n##\n(\"relationship\"<|>C. RIBES KONINCKX<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>C. Ribes Koninckx is an author affiliated with La Fe Hospital Universitari i Politècnic, contributing to research on pediatric care.<|>7)\n##\n(\"relationship\"<|>R. SANCHÍS RAMADA<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>R. Sanchís Ramada is an author affiliated with La Fe Hospital Universitari i Politècnic, contributing to research on pediatric care.<|>7)\n##\n(\"relationship\"<|>C. GUTIÉRREZ SAN ROMAN<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>C. Gutiérrez San Roman is an author affiliated with La Fe Hospital Universitari i Politècnic, contributing to research on pediatric care.<|>7)\n##\n(\"relationship\"<|>J. DALMAU SERRA<|>LA FE HOSPITAL UNIVERSITARI I POLITÈCNIC<|>J. Dalmau Serra is an author affiliated with La Fe Hospital Universitari i Politècnic, contributing to research on pediatric care.<|>7)\n##\n(\"relationship\"<|>CENTRAL VENOUS CATHETER (CVC)<|>C. FUENTES SOCORRO<|>C. Fuentes Socorro discusses complications related to Central Venous Catheters (CVC) in pediatrics.<|>8)\n##\n(\"relationship\"<|>CENTRAL VENOUS CATHETER (CVC)<|>I. VITORIA MIÑANA<|>I. Vitoria Miñana discusses complications related to Central Venous Catheters (CVC) in pediatrics.<|>8)\n##\n(\"relationship\"<|>CENTRAL VENOUS CATHETER (CVC)<|>E. LÓPEZ BRIZ<|>E. López Briz discusses complications related to Central Venous Catheters (CVC) in pediatrics.<|>8)\n##\n(\"relationship\"<|>CENTRAL VENOUS CATHETER (CVC)<|>C. RIBES KONINCKX<|>C. Ribes Koninckx discusses complications related to Central Venous Catheters (CVC) in pediatrics.<|>8)\n##\n(\"relationship\"<|>CENTRAL VENOUS CATHETER (CVC)<|>R. SANCHÍS RAMADA<|>R. Sanchís Ramada discusses complications related to Central Venous Catheters (CVC) in pediatrics.<|>8)\n##\n(\"relationship\"<|>CENTRAL VENOUS CATHETER (CVC)<|>C. GUTIÉRREZ SAN ROMAN<|>C. Gutiérrez San Roman discusses complications related to Central Venous Catheters (CVC) in pediatrics.<|>8)\n##\n(\"relationship\"<|>CENTRAL VENOUS CATHETER (CVC)<|>J. DALMAU SERRA<|>J. Dalmau Serra discusses complications related to Central Venous Catheters (CVC) in pediatrics.<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , INC. 2005; 277-310.\n\n14. Rigo J, Marlowe ML, Bonnot D, Senterre T, Lapillonne A, Kermorvant-Duchemin E, et al. Benefits of a new pediatric triple-chamber bag for parenteral nutrition in preterm infants. J Pediatr Gastroenterol Nutr. 2012;54:210-7\n\n15. Roggero P, Giannì ML, Orsi A, Amato O, Piemontese P, Liotto N, et al. Implementation of nutritional strategies decreases postnatal growth restriction in preterm infants. PLoS ONE 7(12): e51166. doi:10.1371/journal.pone.0051166.\n\n16. Schanler RJ, Shulman RJ, Lau C, Smith EO, Heitkemper MM. Feeding strategies for premature infants: randomized trial of gastrointestinal priming and tube-feeding method. Pediatrics. 1999; 103:434-9.\n\n17. Shah PS, Shah VS. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD002772. DOI:10.1002/14651858.CD002772.pub3.\n\n18. Thureen PJ. Early aggressive nutrition in the neonate. Pediatr Rev. 1999;20:e45-55.\n\n19. Thureen PJ. Nutrición intravenosa y crecimiento postnatal del lactante de peso extremadamente bajo al nacer. Clin Perinat (ed esp). 2000; 1:209-33.\n\n20. Ziegler EE. Alimentación intensiva del lactante con muy bajo peso al nacer. Clin Perinat (ed esp). 2002; 2:205-24.\n---\n# APÉNDICES\n\nThe image shows a medical or educational setting. In the foreground, there are two people sitting in chairs, viewed from behind. In the background, there is a person wearing a white lab coat standing behind a desk with a computer monitor.\n\nAcross the center of the image is a large blue banner with white text that reads \"APÉNDICES\" (which means \"Appendices\" in English).\n\nAt the bottom of the image is a logo and text that reads:\n\nLa Fe\nHospital\nUniversitari\ni Politècnic\n\nThis appears to be the logo and name of a university hospital, likely in a Spanish-speaking country given the language used.\n---\nThe image appears to be a blank white page. There is no visible content, text, diagrams, or any other information present in this image. Therefore, I cannot provide any markdown translation or description of content, as there is nothing to transcribe or describe.\n---\nANEXO I:\n\n# COMPLICACIONES RELACIONADAS CON CATETER VENOSOS CENTRALES DE LARGA DURACIÓN EN PEDIATRÍA.\n\nC. Fuentes Socorro, I. Vitoria Miñana, E. López Briz, C. Ribes Koninckx,\nR. Sanchís Ramada, C. Gutiérrez San Roman, J. Dalmau Serra.\n\n## 1. OBSTRUCCIÓN DE CATETER VENOSO CENTRAL (CVC):\n\nSe presenta en el 14-36% de los CVC con una duración de 1-2 años. Puede ser parcial, cuando no es posible aspirar sangre pero si infundir, o completa, cuando no se puede aspirar ni infundir. Puede deberse a causas mecánicas, precipitación de fármacos o nutrición parenteral, o tener un origen trombótico (tabla 1):\n\n| Diagnóstico | Tratamiento |\n|-------------|-------------|\n| **Obstrucción mecánica** | |\n| -Sutura muy estrecha, acodamiento, malposición | Inspección | Corregir la obstrucción mecánica |\n| -Efecto vacío/bloqueo sobre la pared del vaso | Reposicionar al paciente | Reposicionar al paciente |\n| -Efecto / Síndrome pinch-off* | Radiología | Retirar catéter si riesgo de fractura |\n| **Obstrucción relacionada con fármacos o nutrición parenteral** | |\n| -pH ácido | Revisar fármacos | Ácido clorhídrico 0.1 mol/L ** |\n| -pH alcalótico | Revisar fármacos | Bicarbonato sódico 1 mol/L |\n| -Fosfato cálcico | Revisar fármacos | Ácido clorhídrico 0.1 mol/L ** |\n| -Lípidos | Revisar NP | Etanol 70% ** |\n\n281\n---\n| Obstrucción trombótica | | |\n|---------------------------|----------------|------------------------|\n| -Vaina de fibrina o trombosis intraluminal | Cateterografía | Fármacos trombolíticos intraluminales |\n| -Trombo mural o trombosis venosa | Ecografía | Tratamiento anticoagulante |\n\n\\* El Síndrome pinch-off se presenta cuando una porción del catéter queda comprimida entre la clavícula y la primera costilla al elevar la extremidad\n\n\\\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}